Risk, Outcomes, and Costs of Radiation-Induced Oral Mucositis Among Patients With Head-and-Neck Malignancies

International Journal of Radiation Oncology Biology Physics

Volumn 68, Issue 4, 2007, Pages 1110-1120

  Elting, Linda S ^a   Cooksley, Catherine D ^a   Chambers, Mark S ^a   Garden, Adam S ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Cost; Head and neck cancer; Oral mucositis; Outcomes; Radiotherapy

Indexed keywords

HEAD-AND-NECK CANCER; ORAL MUCOSITIS; OUTCOMES; PREVENTIVE STRATEGIES;

CHEMOTHERAPY; COSTS; FRACTIONATION; ONCOLOGY; RADIOTHERAPY; RISK ASSESSMENT;

PATIENT MONITORING;

PLATINUM DERIVATIVE; TAXANE DERIVATIVE;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CONFIDENCE INTERVAL; CONTROLLED STUDY; COST; COST OF ILLNESS; DATA ANALYSIS; DISEASE SEVERITY; FEMALE; FRACTIONATION; HEAD AND NECK CANCER; HUMAN; MALE; MEDICAL RECORD; MOUTH CAVITY; MUCOSA INFLAMMATION; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; OROPHARYNX; PAIN; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; TREATMENT OUTCOME; WEIGHT REDUCTION;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ANTINEOPLASTIC AGENTS; COHORT STUDIES; COSTS AND COST ANALYSIS; EATING; FEMALE; HEAD AND NECK NEOPLASMS; HEALTH CARE COSTS; HUMANS; MALE; MIDDLE AGED; RADIATION INJURIES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; STOMATITIS;

EID: 34447260509     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2007.01.053     Document Type: Article

References (28)

1. Trotti A. Toxicity in head and neck cancer: A review of trends and issues. Int J Radiat Oncol Biol Phys 47 (2000) 1-12
2. Chambers M.S., Garden A.S., Rosenthal D., et al. Intensity-modulated radiotherapy: Is xerostomia still prevalent?. Curr Oncol Rep 7 (2005) 131-136
3. List M.A., Siston A., Haraf D., et al. Quality of life and performance in advanced head and neck cancer patients on concomitant chemoradiotherapy: A prospective examination. J Clin Oncol 17 (1999) 1020-1028
4. Terrell J.E., Ronis D.L., Fowler K.E., et al. Clinical predictors of quality of life in patients with head and neck cancer. Arch Otolaryngol Head Neck Surg 130 (2004) 401-408
5. Garden A.S., Lewin J.S., and Chambers M.S. How to reduce radiation-related toxicity in patients with cancer of the head and neck. Curr Oncol Rep 8 (2006) 140-145
6. Garden A.S., Morrison W.H., Wong P.F., et al. Disease-control rates following intensity-modulated radiation therapy for small primary oropharyngeal carcinoma. Int J Radiat Oncol Biol Phys 67 (2007) 438-444
7. National Cancer Institute. Cancer Therapy Evaluation Program. Common toxicity criteria, V2.0 (1999). http://ctep.cancer.gov/reporting/ctc_archive.html August. Available at: http://ctep.cancer.gov/reporting/ctc_archive.html. Accessed October 24, 2006
8. Ang K.K., Peters L.J., Weber R.S., et al. Concomitant boost radiotherapy schedules in the treatment of carcinoma of the oropharynx and nasopharynx. Int J Radiat Oncol Biol Phys 19 (1990) 1339-1345
9. Fu K.K., Pajak T.F., Trotti A., et al. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: First report of RTOG 9003. Int J Radiat Oncol Biol Phys 48 (2000) 7-16
10. Trotti A., Bellm L.A., Epstein J.B., et al. Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: A systematic literature review. Radiother Oncol 66 (2003) 253-262
11. Delaney G.P., Fisher R.J., Smee R.I., et al. Split-course accelerated therapy in head and neck cancer: An analysis of toxicity. Int J Radiat Oncol Biol Phys 32 (1995) 763-768
12. Sonis S.T., and Fey E.G. Oral complications of cancer therapy. Oncology (Williston Park, NY) 16 (2002) 680-686 discussion 686, 691-692, 695
13. Vera-Llonch M., Oster G., Hagiwara M., et al. Oral mucositis in patients undergoing radiation treatment for head and neck carcinoma. Cancer 106 (2006) 329-336
14. Sonis S.T., Elting L.S., Keefe D., et al. Perspectives on cancer therapy-induced mucosal injury: Pathogenesis, measurement, epidemiology, and consequences for patients. Cancer 100 (2004) 1995-2025
15. Epstein J.B., Emerton S., Kolbinson D.A., et al. Quality of life and oral function following radiotherapy for head and neck cancer. Head Neck 21 (1999) 1-11
16. Rose-Ped A.M., Bellm L.A., Epstein J.B., et al. Complications of radiation therapy for head and neck cancers. The patient's perspective. Cancer Nurs 25 (2002) 461-467 quiz 468-469
17. Stiff P.J., Emmanouilides C., Bensinger W.I., et al. Palifermin reduces patient-reported mouth and throat soreness and improves patient functioning in the hematopoietic stem-cell transplantation setting. J Clin Oncol 24 (2006) 5186-5193
18. Elting L.S., Bodey G.P., and Keefe B.H. Septicemia and shock syndrome due to viridans streptococci: A case-control study of predisposing factors. Clin Infect Dis 14 (1992) 1201-1207
19. Ruescher T.J., Sodeifi A., Scrivani S.J., et al. The impact of mucositis on alpha-hemolytic streptococcal infection in patients undergoing autologous bone marrow transplantation for hematologic malignancies. Cancer 82 (1998) 2275-2281
20. Spielberger R., Stiff P., Bensinger W., et al. Palifermin for oral mucositis after intensive therapy for hematologic cancers. N Engl J Med 351 (2004) 2590-2598
21. Chen M.L., and Tseng H.C. Symptom clusters in cancer patients. Support Care Cancer 14 (2006) 825-830
22. Cleeland C.S., Bennett G.J., Dantzer R., et al. Are the symptoms of cancer and cancer treatment due to a shared biologic mechanism?. A cytokine-immunologic model of cancer symptoms. Cancer 97 (2003) 2919-2925
23. Kelley K.W., Bluthe R.M., Dantzer R., et al. Cytokine-induced sickness behavior. Brain Behav Immun 17 Suppl. 1 (2003) S112-S118
24. Walsh D., and Rybicki L. Symptom clustering in advanced cancer. Support Care Cancer 14 (2006) 831-836
25. Hart B.L. Biological basis of the behavior of sick animals. Neurosci Biobehav Rev 12 (1988) 123-137
26. Anthony L., Bowen J., Garden A., et al. New thoughts on the pathobiology of regimen-related mucosal injury. Support Care Cancer 14 (2006) 516-518
27. Peterman A., Cella D., Glandon G., et al. Mucositis in head and neck cancer: Economic and quality-of-life outcomes. J Natl Cancer Inst Monogr 29 (2001) 45-51
28. Elting L.S., Cooksley C., Chambers M., et al. The burdens of cancer therapy. Clinical and economic outcomes of chemotherapy-induced mucositis. Cancer 98 (2003) 1531-1539